Addiction Toxicology Case Conference - February 2025

Addiction Toxicology Case Conference - February 2025

Includes a Live Web Event on 02/14/2025 at 1:00 PM (EST)

  • Register
    • Non-member - Tier I - Free!
    • Non-member - Tier II - Free!
    • Non-member - Tier III - Free!
    • Non-member - Tier IV - Free!
    • Member - Tier I - Free!
    • Member - Tier II - Free!
    • Member - Tier III - Free!
    • Member - Tier IV - Free!

Driving Impairment and Medical Legal Issues

Friday, February 14, 2025
1:00-2:00pm ET

Cases to be announced soon!


Learning Objectives
  • Identify the pharmacological effects of alcohol, cannabis, opioids, and other drugs on driving ability.

  • Promote harm reduction and effective patient counseling approaches.

  • Evaluate the reliability and relevance of blood, urine, and breath testing in determining impairment at the time of driving.

Continuing Education

1.25 Continuing Education credits for Physicians and Nurses available ($20 certificate fee). Click here for more info.


About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.

This webinar is free and open to the public.

Jeffrey Brent, MD, PhD, FACMT

Distinguished Clinical Professor of Medicine (Pulmonary and Critical Care) and Emergency Medicine

University of Colorado School of Medicine and Public Health

Jeffrey Brent, MD, PhD, is a Distinguished Clinical Professor of Medicine (Pulmonary and Critical Care Medicine) and Emergency Medicine at the University of Colorado Schools of Medicine and Public Health. He did his fellowship in medical toxicology at the Rocky Mountain Poison and Drug Center, where he has been both medical director and fellowship director. He is a former President of the American Academy of Clinical Toxicology and a former Board member of the American College of Medical Toxicology. Dr. Brent is the senior editor of Critical Care Toxicology: the Diagnosis and Management of the Critically Poisoned Patient, currently in its second edition. Dr. Brent is Co-Principal Investigator of ACMT’s Toxicology Investigators Consortium.

Barry Logan, PhD, F-ABFT

Executive Director, Sr. VP & Chief Scientist Forensic Sciences

Center for Forensic Science Research and Education & NMS Labs

Dr. Barry Logan is the Senior Vice President of Forensic Sciences and Chief Scientist at NMS Labs, as well as the Executive Director of the Center for Forensic Science Research and Education (CFSRE) at the Fredric Rieders Family Foundation. A Fellow of the American Board of Forensic Toxicologists (ABFT), Dr. Logan has over 190 publications exploring topics such as the effects of drugs on drivers, drug-related fatalities, and novel psychoactive substances. His current research focuses on new drug surveillance, the polydrug crisis, and the chemistry of emerging substances, leading to the founding of NPSDiscovery.org in 2018. He holds academic appointments at Indiana University, Arcadia University, and Thomas Jefferson University, and serves on the advisory board for NIDA’s National Drug Early Warning System (NDEWS). A past president of the American Academy of Forensic Sciences (AAFS), Dr. Logan was honored with TIAFT’s Alan Curry Award in 2022 for his significant contributions to forensic toxicology.

Michael G. Holland, MD, FEAPCCT, FAACT, FACOEM, FACMT, FACEP

Professor of Emergency Medicine

SUNY Upstate Medical University

Dr. Holland is Clinical Professor of Emergency Medicine at SUNY Upstate Medical University in Syracuse, NY where he is on the faculty of the Medical Toxicology Fellowship Training Program and is a Consulting Medical Toxicologist at the Upstate New York Poison Center and the Onondaga County Medical Examiner’s Office-both in Syracuse, NY. Dr. Holland is also the Director of Occupational Medicine for the Saratoga Hospital Medical Group, and is the Saratoga Hospital Employee Health Medical Director, where he oversees the health and safety of over 3100 employees and staff. He also serves as Employee Health Medical Director at Glens Falls Hospital in Glens Falls, NY, covering 2500 employees. He is also Principal Medical Toxicologist at the Center for Toxicology and Environmental Health (CTEH) in Little Rock, AR.    

Charles McKay, MD, FACMT

Associate Medical Director

CT Poison Control Center, University of Connecticut School of Medicine

Dr. McKay was trained in Anatomic and Surgical Pathology, Internal Medicine, Emergency Medicine, Medical Toxicology and was a Medical Director of Occupational Health and Medical Review Officer for a hospital system during more than 30 years of clinical practice, during which he provided toxicology consultation at 3 hospitals, directed a medical toxicology fellowship training program, and provided medical oversight of a regional poison control center. He provides medical legal consultation across the country on toxicology-related issues, and has testified in nearly 100 cases, many related to questions of alcohol- and -drug-induced impairment.

Timothy Wiegand, MD, DFASAM, FACMT, FAACT (Moderator)

Director of Addiction Medicine and Addiction Medicine Consults

University of Rochester Medical Center

Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center (URMC) in Rochester, New York. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). In 2023, he began a two-year term as Treasurer of ASAM, having previously served as Vice President on the Executive Council. Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.

Gloria Baciewicz, MD (Moderator)

Addiction Psychiatrist

Strong Recovery

Since 1986, Gloria Baciewicz has specialized in the treatment of addiction. Professor of clinical psychiatry at the University of Rochester Medical Center, she serves as an addiction psychiatrist at Strong Recovery. Dr. Baciewicz is certified in addiction medicine by the American Board of Preventive Medicine and board certified in psychiatry, with added qualifications in addiction psychiatry. Dr. Baciewicz is a co-principal investigator for the University of Rochester’s Recovery Center of Excellence.

Continuing Education
image

Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare, and is available for an additional fee ($20 administrative fee per certificate).

image

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.


Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live virtual and enduring activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For physicians, hours of participation are the number of AMA PRA Category 1 Credit(s)™ awarded.

Nurses
Credit being awarded: 1.25 ANCC contact hours.


Commercial Support
There is no commercial support for this activity.


Timothy J. Wiegand, MD, FACMT, DFASAM, Lead Physician Planner/Reviewer/Faculty: has nothing to disclose.
Gloria J. Baciewicz, MD, Physician Planner/Reviewer/Faculty: has nothing to disclose.
Jeffrey Brent, MD, PhD Faculty: has nothing to disclose
Barry Logan, PhD, Faculty: has nothing to disclose
Michael Holland, MD, Faculty: has nothing to disclose
Charles McKay, MD, Faculty: has nothing to disclose

ACMT Planners and Reviewers: have nothing to disclose.
AKH Planners and Reviewers: have nothing to disclose.

None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All of the relevant financial relationships listed for these individuals have been mitigated.


Disclosures

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product 

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer 

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.comwith your information with "Opt Out" in the subject line.

Key:

Complete
Failed
Available
Locked
Attendance: Who's Watching?
8 Questions
8 Questions Help us track metrics for our webinar series by answering these quick questions.
ATCC - February 2025
02/14/2025 at 1:00 PM (EST)  |  60 minutes  |  Attendance Required
02/14/2025 at 1:00 PM (EST)  |  60 minutes  |  Attendance Required
Feedback Survey
5 Questions
Attendance Certificate
Live and Archive Viewing: No credits available and certificate available
Live and Archive Viewing: No credits available and certificate available This is an optional certificate verifying that you attended this webinar. Please note that this is NOT a certificate for continuing education credits.
Continuing Education - $20 Certificate Fee
Purchase or Claim Credits
Select the "Click here" button to begin.
Select the "Click here" button to begin. 1.25 CME or CNE credits available for an additional fee.